$64.02
+2.10 (+3.39%)
Performance
1D
—
1W
+3.21%
1M
-4.39%
3M
+9.83%
6M
+18.58%
1Y
+53.49%
YTD
+37.80%
Open$61.89
Previous Close$61.92
Day High$65.31
Day Low$61.14
52W High$90.75
52W Low$39.87
Volume—
Avg Volume2.41M
Market Cap9.76B
P/E Ratio—
EPS$-7.64
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$61.64
Above
SMA 200
$57.26
Above
RSI (14)
51
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+4.8% upside
Current
$64.02
$64.02
Target
$67.08
$67.08
$56.09
$67.08 avg
$108.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.07B | 3.02B | 2.41B |
| Net Income | 147.42M | 150.65M | 124.53M |
| Profit Margin | 4.8% | 5.0% | 5.2% |
| EBITDA | 264.93M | 279.22M | 238.21M |
| Free Cash Flow | 132.34M | 114.72M | 94.55M |
| Rev Growth | +1.9% | +8.9% | +10.2% |
| Debt/Equity | 1.24 | 1.35 | 1.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.34 | +1.08% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $461.10 | +0.18% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $168.18 | +0.36% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $546.92 | +0.81% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $908.12 | +0.58% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $157.53 | +0.56% | 28.8 | 23.28B |